# Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation

> **NCT00404053** · PHASE4 · COMPLETED · sponsor: **Shenyang Northern Hospital**

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00404053
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** — (—)
- **Last updated:** 2006-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404053, "Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00404053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*